183 related articles for article (PubMed ID: 31352911)
1. Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis.
Tölle D; Hentrich M; Pelzer BW; Kremer P; Einhell S; Schulz S; Böll B; Panse J; Schmidt-Hieber M; Teschner D; Schalk E
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1204-1206. PubMed ID: 31352911
[No Abstract] [Full Text] [Related]
2. Determination of a Cutoff Time Point for Prophylactic Exchange of Central Venous Catheters for Prevention of Central Venous Catheter-Related Bloodstream Infections in Patients with Hematological Malignancies.
Schalk E; Biehl LM; Färber J; Schlüter D; Vehreschild MJGT; Fischer T
Infect Control Hosp Epidemiol; 2017 Jul; 38(7):888-889. PubMed ID: 28514979
[No Abstract] [Full Text] [Related]
3. Which trial do we need? Scheduled central venous catheter removal vs. routine clinical care for prevention of central venous catheter-related bloodstream infections in patients with haematologic malignancies.
Schalk E; Panse J
Clin Microbiol Infect; 2023 Apr; 29(4):417-418. PubMed ID: 36639031
[No Abstract] [Full Text] [Related]
4. Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic.
Schalk E; Schmitt T; Panse J; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Mougiakakos D
Br J Haematol; 2022 Nov; 199(4):e16-e20. PubMed ID: 36017820
[No Abstract] [Full Text] [Related]
5. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D; Berisha M; Panse J; Schmitt T; Fiegle E; Naendrup JH; Neitz J; Schmidt-Hieber M; Hentrich M; Böll B; Schalk E
Eur J Haematol; 2023 Dec; 111(6):914-921. PubMed ID: 37705250
[TBL] [Abstract][Full Text] [Related]
6. Effect of ultrasound-guided central venous catheter insertion on the incidence of catheter-related bloodstream infections and mechanical complications.
Imataki O; Shimatani M; Ohue Y; Uemura M
BMC Infect Dis; 2019 Oct; 19(1):857. PubMed ID: 31619174
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for central venous catheter-related bloodstream infection in neonates.
Ferreira J; Camargos PAM; Rosado V; Mourão PHO; Romanelli RMC
Am J Infect Control; 2020 Sep; 48(9):1102-1103. PubMed ID: 31926756
[TBL] [Abstract][Full Text] [Related]
9. Bundle Approach to Reduce Bloodstream Infections in Neutropenic Hematologic Patients with a Long-Term Central Venous Catheter.
Martinez JM; Leite L; França D; Capela R; Viterbo L; Varajão N; Martins Â; Oliveira I; Domingues N; Moreira I; Santo A; Trigo F; Mariz J
Acta Med Port; 2015; 28(4):474-9. PubMed ID: 26574983
[TBL] [Abstract][Full Text] [Related]
10. Central Venous Catheter-Related Bloodstream Infections in Obese Hematologic Patients.
Schalk E; Färber J; Fischer T; Heidel FH
Infect Control Hosp Epidemiol; 2015 Aug; 36(8):995-6. PubMed ID: 25990462
[No Abstract] [Full Text] [Related]
11. Influence of different definitions of central venous catheter-related bloodstream infections on epidemiological parameters in cancer patients.
Schalk E; Vehreschild MJGT; Biehl LM
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):501-503. PubMed ID: 32631475
[No Abstract] [Full Text] [Related]
12. Overweight or obesity are not risk factors for central venous catheter-related bloodstream infections in patients with hematological malignancies.
Schalk E; Hentrich M
Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1953-1955. PubMed ID: 34924070
[No Abstract] [Full Text] [Related]
13. Insertion site inflammation was associated with central-line-associated bloodstream infections at a tertiary-care center, 2015-2018.
Kobayashi T; Clore GS; Kukla ME; Alzunitan M; Kritzman J; Abosi O; Puig-Asensio M; Marra AR; Diekema DJ; Edmond MB; Salinas JL
Infect Control Hosp Epidemiol; 2021 Mar; 42(3):348-350. PubMed ID: 33032671
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the incidence of midline catheter-associated bloodstream infections to that of central line-associated bloodstream infections in 5 acute care hospitals.
Hogle NJ; Balzer KM; Ross BG; Wuerz L; Greendyke WG; Furuya EY; Simon MS; Calfee DP
Am J Infect Control; 2020 Sep; 48(9):1108-1110. PubMed ID: 31812270
[TBL] [Abstract][Full Text] [Related]
15. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients.
Chaftari AM; Hachem R; Jiang Y; Shah P; Hussain A; Hamal ZA; Yousif A; Jordan M; Michael M; Raad I
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):727-729. PubMed ID: 29770754
[TBL] [Abstract][Full Text] [Related]
16. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
[TBL] [Abstract][Full Text] [Related]
17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
18. A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.
Picardi M; Della Pepa R; Cerchione C; Pugliese N; Mortaruolo C; Trastulli F; Giordano C; Grimaldi F; Zacheo I; Raimondo M; Chiurazzi F; Pane F
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):e184-e194. PubMed ID: 30704933
[TBL] [Abstract][Full Text] [Related]
19. Jugular vein inserted central venous catheters (CVC) and the risk of CVC-related bloodstream infections in patients with hematological malignancies.
Schalk E; Biehl LM; Böll B
Am J Hematol; 2022 Sep; 97(9):E336-E340. PubMed ID: 35713556
[No Abstract] [Full Text] [Related]
20. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
